Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Senior

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Nature Biotechnology|June 10, 2026
Biotech's coming of ageMelanie Senior
Nature Biotechnology|January 11, 2014
FDA halts then allows sales of Ariad's leukemia medicationMelanie Senior
Nature Biotechnology|July 9, 2021
China at the thresholdMelanie Senior
Nature Biotechnology|August 8, 2024
Biotech financing: darkest before the dawnMelanie Senior
Nature Biotechnology|November 19, 2025
Heart matters: new treatments, tools and access channelsMelanie Senior
Nature Cancer|December 17, 2024
Beyond the hype of AI in cancer R&DMelanie Senior
Nature Biotechnology|March 8, 2017
Billion-dollar deals end eras of Ariad and ActelionMelanie Senior
Nature Biotechnology|June 16, 2025
Biotech financing: divide and resetMelanie Senior
Nature Biotechnology|June 12, 2013
Family offices bolster early-stage financingMelanie Senior
Nature Biotechnology|January 19, 2026
Fresh from the biotech pipeline: FDA turmoil overshadows 2025 approvalsMelanie Senior
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Nature Biotechnology|June 10, 2026
Biotech's coming of ageMelanie Senior
Nature Biotechnology|January 11, 2014
FDA halts then allows sales of Ariad's leukemia medicationMelanie Senior
Nature Biotechnology|July 9, 2021
China at the thresholdMelanie Senior
Nature Biotechnology|August 8, 2024
Biotech financing: darkest before the dawnMelanie Senior
Nature Biotechnology|November 19, 2025
Heart matters: new treatments, tools and access channelsMelanie Senior
Nature Cancer|December 17, 2024
Beyond the hype of AI in cancer R&DMelanie Senior
Nature Biotechnology|March 8, 2017
Billion-dollar deals end eras of Ariad and ActelionMelanie Senior
Nature Biotechnology|June 16, 2025
Biotech financing: divide and resetMelanie Senior
Nature Biotechnology|June 12, 2013
Family offices bolster early-stage financingMelanie Senior
Nature Biotechnology|January 19, 2026
Fresh from the biotech pipeline: FDA turmoil overshadows 2025 approvalsMelanie Senior
Pageof 6